408 related articles for article (PubMed ID: 34424546)
1. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V; Carter B; Putman M
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD008901. PubMed ID: 34424546
[TBL] [Abstract][Full Text] [Related]
2. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V; Carter B; Putman M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD008901. PubMed ID: 30557452
[TBL] [Abstract][Full Text] [Related]
3. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V; Haagensen AL; Carter B; Fedorowicz Z; Houston BW
Cochrane Database Syst Rev; 2015 May; (5):CD008901. PubMed ID: 25991406
[TBL] [Abstract][Full Text] [Related]
4. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V; Haagensen AL; Carter B; Fedorowicz Z; Houston BW
Cochrane Database Syst Rev; 2013 Jun; 6(6):CD008901. PubMed ID: 23737090
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
Southern KW; Solis-Moya A; Kurz D; Smith S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
[TBL] [Abstract][Full Text] [Related]
7. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM; Smith S
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD001506. PubMed ID: 37319354
[TBL] [Abstract][Full Text] [Related]
8. Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis.
Dawson S; Girling CJ; Cowap L; Clark-Carter D
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013766. PubMed ID: 36989170
[TBL] [Abstract][Full Text] [Related]
9. Physical activity and exercise training in cystic fibrosis.
Radtke T; Smith S; Nevitt SJ; Hebestreit H; Kriemler S
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD002768. PubMed ID: 35943025
[TBL] [Abstract][Full Text] [Related]
10. Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis.
Warnock L; Gates A
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD001401. PubMed ID: 37042825
[TBL] [Abstract][Full Text] [Related]
11. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
[TBL] [Abstract][Full Text] [Related]
12. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
13. Probiotics for people with cystic fibrosis.
Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
[TBL] [Abstract][Full Text] [Related]
14. Short-acting inhaled bronchodilators for cystic fibrosis.
Smith S; Rowbotham NJ; Edwards CT
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013666. PubMed ID: 35749226
[TBL] [Abstract][Full Text] [Related]
15. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Smith S; Rowbotham NJ
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smith S; Rowbotham NJ; Yule A; Smyth AR
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD004197. PubMed ID: 37268599
[TBL] [Abstract][Full Text] [Related]
17. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright CE; Smyth AR
Cochrane Database Syst Rev; 2024 May; 5(5):CD009530. PubMed ID: 38700027
[TBL] [Abstract][Full Text] [Related]
18. Exercise versus airway clearance techniques for people with cystic fibrosis.
Heinz KD; Walsh A; Southern KW; Johnstone Z; Regan KH
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013285. PubMed ID: 35731672
[TBL] [Abstract][Full Text] [Related]
19. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008319. PubMed ID: 35914011
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]